| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in NTRA over the last quarter tilts toward selling: insiders offloaded a net 278,788 shares worth roughly $65.7M. In the past 30 days, 0 insiders bought and 8 sold. The bias lately has been to the sell side.
Not all activity pointed one way: 8 insiders sold in the same window, though all of them still hold shares. Classified under Life Sciences Tools & Services (Health Care sector), NTRA's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 245.5K | $79.08M | -14,388 | |
| Pres | 183.8K | $59.19M | -2,008 | |
| Other | 170.1K | $54.78M | -2,221 | |
| Pres | 129.0K | $41.56M | -5,624 | |
| CEO | 101.8K | $32.79M | -8,846 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 13, 2023 | Chapman Rowan E52 | Director | Sell | 1,767 | $50.58 | $89,366.03 | -17.0% | +7.6% | +122.0% | |
| Jun 7, 2023 | Sheena Jonathan46 | Director, Co-founder | Sell | 5,652 | $49.10 | $277,533.22 | -0.5% | +19.9% | +120.4% |